LAVIPHARM S.A. NA EO 1 Defensive Interval Ratio
LAVIPHARM S.A. NA EO 1 defensive interval ratio. LAVIPHARM S.A. NA EO 1 (BXA0) has a Defensive Interval Ratio of 146 days as of December 2024. Defensive assets of €15.61 Million (cash €-, short-term investments €-, receivables €15.61 Million) cover 146 days of daily cash needs of €107.19K/day. See LAVIPHARM S.A. NA EO 1 working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of LAVIPHARM S.A. NA EO 1 (2021–2024)
Defensive interval ratio of LAVIPHARM S.A. NA EO 1 from 2021 to 2024. This chart shows how LAVIPHARM S.A. NA EO 1's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the ratio stands at 146 days, meaning defensive assets of €15.61 Million can fund 146 days of operations without new revenue. Check BXA0 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
LAVIPHARM S.A. NA EO 1 Defensive Interval Ratio by Year (2021–2024)
LAVIPHARM S.A. NA EO 1 defensive interval ratio by year from 2021 to 2024. The table below presents the year-by-year Defensive Interval Ratio for LAVIPHARM S.A. NA EO 1 from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see BXA0 current and non-current assets.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 146 days | €15.61 Million | €107.19K/day | €- | €- | ▼ -76 days |
| 2023 | 221 days | €21.70 Million | €98.08K/day | €- | €3.00K | ▲ +85 days |
| 2022 | 137 days | €17.13 Million | €125.32K/day | €- | €1.00K | ▼ -3 days |
| 2021 | 139 days | €15.66 Million | €112.51K/day | €- | €- | — |